CRGX vs. AKBA, NRIX, AVXL, IMNM, RCKT, AVBP, DAWN, TRVI, IMTX, and SION
Should you be buying CARGO Therapeutics stock or one of its competitors? The main competitors of CARGO Therapeutics include Akebia Therapeutics (AKBA), Nurix Therapeutics (NRIX), Anavex Life Sciences (AVXL), Immunome (IMNM), Rocket Pharmaceuticals (RCKT), ArriVent BioPharma (AVBP), Day One Biopharmaceuticals (DAWN), Trevi Therapeutics (TRVI), Immatics (IMTX), and Sionna Therapeutics (SION). These companies are all part of the "pharmaceutical products" industry.
CARGO Therapeutics vs.
Akebia Therapeutics (NASDAQ:AKBA) and CARGO Therapeutics (NASDAQ:CRGX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, valuation, risk, earnings, profitability, institutional ownership, analyst recommendations and community ranking.
33.9% of Akebia Therapeutics shares are held by institutional investors. Comparatively, 93.2% of CARGO Therapeutics shares are held by institutional investors. 3.0% of Akebia Therapeutics shares are held by insiders. Comparatively, 2.9% of CARGO Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Akebia Therapeutics received 408 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. However, 66.67% of users gave CARGO Therapeutics an outperform vote while only 63.08% of users gave Akebia Therapeutics an outperform vote.
CARGO Therapeutics has a net margin of 0.00% compared to Akebia Therapeutics' net margin of -27.07%. Akebia Therapeutics' return on equity of 0.00% beat CARGO Therapeutics' return on equity.
Akebia Therapeutics has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500. Comparatively, CARGO Therapeutics has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500.
In the previous week, Akebia Therapeutics had 2 more articles in the media than CARGO Therapeutics. MarketBeat recorded 4 mentions for Akebia Therapeutics and 2 mentions for CARGO Therapeutics. CARGO Therapeutics' average media sentiment score of 1.51 beat Akebia Therapeutics' score of 1.46 indicating that CARGO Therapeutics is being referred to more favorably in the news media.
Akebia Therapeutics presently has a consensus price target of $6.63, suggesting a potential upside of 135.77%. CARGO Therapeutics has a consensus price target of $15.00, suggesting a potential upside of 269.46%. Given CARGO Therapeutics' higher probable upside, analysts plainly believe CARGO Therapeutics is more favorable than Akebia Therapeutics.
Akebia Therapeutics has higher revenue and earnings than CARGO Therapeutics. Akebia Therapeutics is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks.
Summary
Akebia Therapeutics beats CARGO Therapeutics on 12 of the 18 factors compared between the two stocks.
Get CARGO Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CARGO Therapeutics Competitors List
Related Companies and Tools
This page (NASDAQ:CRGX) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy CRGX Stock Free CRGX Stock Alerts